ASRT vs IT · rev $125.0M vs P/E 16, rev $6.27B
Assertio Therapeutics Inc (ASRT) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ASRT currently screens at market cap $151.5M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ASRT and IT stock pages for the full models.
Not investment advice.